{"id":1402,"date":"2026-02-18T13:00:13","date_gmt":"2026-02-18T13:00:13","guid":{"rendered":"https:\/\/wickedsister.evit.com.au\/index.php\/2026\/02\/18\/funding-to-support-immunic-phase-3-ms-trials-commercialization\/"},"modified":"2026-02-18T13:00:13","modified_gmt":"2026-02-18T13:00:13","slug":"funding-to-support-immunic-phase-3-ms-trials-commercialization","status":"publish","type":"post","link":"https:\/\/wickedsister.evit.com.au\/index.php\/2026\/02\/18\/funding-to-support-immunic-phase-3-ms-trials-commercialization\/","title":{"rendered":"Funding to support Immunic Phase 3 MS trials, commercialization"},"content":{"rendered":"<p><a href=\"https:\/\/multiplesclerosisnewstoday.com\/news-posts\/2026\/02\/18\/funding-support-immunic-phase-3-ms-trials-commercialization\/\" title=\"Funding to support Immunic Phase 3 MS trials, commercialization\" rel=\"nofollow\"><img loading=\"lazy\" decoding=\"async\" width=\"800\" height=\"533\" src=\"https:\/\/multiplesclerosisnewstoday.com\/wp-content\/uploads\/2026\/02\/iStock-2197655310-800x533.jpg\" class=\"webfeedsFeaturedVisual wp-post-image\" alt=\"Three people look at data with graphs and charts shown on a tablet and papers with a laptop nearby.\" style=\"margin: auto;margin-bottom: 15px;max-width: 100%\" data-wp-pid=\"159496\" \/><\/a><\/p>\n<p>Immunic Therapeutics has closed a private placement that could provide up to $400 million to support the company&#8217;s Phase 3 clinical program of vidofludimus calcium in multiple sclerosis (MS) and help fund its transition into a commercial-stage company as it prepares for potential regulatory approval of the oral therapy. The financing will support completion of [&#8230;]<\/p>\n<p>The post <a href=\"https:\/\/multiplesclerosisnewstoday.com\/news-posts\/2026\/02\/18\/funding-support-immunic-phase-3-ms-trials-commercialization\/\">Funding to support Immunic Phase 3 MS trials, commercialization<\/a> appeared first on <a href=\"https:\/\/multiplesclerosisnewstoday.com\">Multiple Sclerosis News Today<\/a>.<\/p>\n<p><em>Source: <a href=\"https:\/\/multiplesclerosisnewstoday.com\/news-posts\/2026\/02\/18\/funding-support-immunic-phase-3-ms-trials-commercialization\/\" rel=\"nofollow noopener\" target=\"_blank\">multiplesclerosisnewstoday.com<\/a><\/em><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Immunic Therapeutics has closed a private placement that could provide up to $400 million to support the company&#8217;s Phase 3 clinical program of vidofludimus calcium in multiple sclerosis (MS) and help fund its transition into a commercial-stage company as it prepares for potential regulatory approval of the oral therapy. The financing will support completion of&#8230;<\/p>\n","protected":false},"author":0,"featured_media":1403,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[4],"tags":[11,15,9,8,13,14,12,10],"class_list":["post-1402","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-multiple-sclerosis-research","tag-brain-repair","tag-marburg-type-ms","tag-ms","tag-multiple-sclerosis","tag-myelin","tag-neuroregeneration","tag-oligodendrocyte","tag-remyelination"],"_links":{"self":[{"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/posts\/1402","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/comments?post=1402"}],"version-history":[{"count":0,"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/posts\/1402\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/media\/1403"}],"wp:attachment":[{"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/media?parent=1402"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/categories?post=1402"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/tags?post=1402"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}